title: Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma.
abstract: The majority of women diagnosed with epithelial ovarian carcinoma (EOC) succumb due to complications of metastatic disease, suggesting that antimetastatic therapies may improve patient survival. EOC metastasis involves intraperitoneal shedding of cells from the primary tumor, followed by adhesion and localized penetration of the submesothelial matrix to anchor metastatic implants. Accumulation of malignant ascites is also common. Thus, a unique microenvironmental niche is established, which includes malignant cells and a plethora of soluble factors secreted by-or in response to-tumor cells. As cells penetrating the submesothelial surface encounter an interstitial collagen-rich extracellular matrix, we have used three-dimensional type I collagen gels to model early events resulting from intraperitoneal anchoring. In this study, we show a novel pathway of CXCR4 upregulation through beta1 integrin - and NFkappaB-dependent signaling pathways in response to three-dimensional type I collagen. We also show the involvement of CXCR4-SDF1 axis in collagen invasion and proliferation, relevant to the metastatic EOC. Our data show that CXCR4 expression in human EOCs, as well as SDF1 presence in the ascites, is correlated with disease progression and metastasis. These data emphasize the importance of the CXCR4-SDF1 axis in EOC metastasis and suggest that this mechanism should be accounted for when targeting EOC metastasis.
authors.affiliation: Department of Biopharmaceutical Sciences, University of Illinois at Chicago, 833 South Wood Street, PHARM 355, Chicago, IL 60612, USA. mvb@uic.edu
authors.forename: Maria V
authors.initials: MV
authors.lastname: Barbolina
authors.forename: Mijung
authors.initials: M
authors.lastname: Kim
authors.forename: Yueying
authors.initials: Y
authors.lastname: Liu
authors.forename: Jaclyn
authors.initials: J
authors.lastname: Shepard
authors.forename: Abdelhak
authors.initials: A
authors.lastname: Belmadani
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Miller
authors.forename: Lonnie D
authors.initials: LD
authors.lastname: Shea
authors.forename: M Sharon
authors.initials: MS
authors.lastname: Stack
mesh_terms: D002277:Carcinoma / Q000378:metabolism* / Q000473:pathology / Q000517:prevention & control; D002448:Cell Adhesion / Q000502:physiology; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000502:physiology; D054377:Chemokine CXCL12 / Q000502:physiology; D003094:Collagen / Q000378:metabolism; D005109:Extracellular Matrix / Q000502:physiology; D005260:Female; D006801:Humans; D019012:Integrin beta1 / Q000502:physiology; D009362:Neoplasm Metastasis / Q000235:genetics / Q000473:pathology*; D009924:Organ Culture Techniques; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000517:prevention & control; D034741:RNA, Small Interfering / Q000502:physiology; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*
chemical_list: C515255:CXCL12 protein, human; C527276:CXCR4 protein, human; D054377:Chemokine CXCL12; D019012:Integrin beta1; D034741:RNA, Small Interfering; D019718:Receptors, CXCR4; D003094:Collagen
references.citation: J Biol Chem. 2003 Jun 13;278(24):21631-8
references.pmid: 12690099
references.citation: Aging Cell. 2005 Dec;4(6):291-8
references.pmid: 16300481
references.citation: Nat Rev Drug Discov. 2003 Jul;2(7):581-7
references.pmid: 12815382
references.citation: Cancer Res. 2004 Apr 1;64(7):2534-43
references.pmid: 15059909
references.citation: Am J Pathol. 2009 Feb;174(2):602-12
references.pmid: 19147814
references.citation: Eur J Haematol. 2000 Mar;64(3):164-72
references.pmid: 10997882
references.citation: J Mol Endocrinol. 2007 Mar;38(3):377-82
references.pmid: 17339400
references.citation: Oncogene. 2003 Feb 20;22(7):974-82
references.pmid: 12592384
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Chin Med J (Engl). 2007 Jul 20;120(14):1251-5
references.pmid: 17697577
references.citation: Nature. 2001 Mar 1;410(6824):50-6
references.pmid: 11242036
references.citation: Clin Exp Metastasis. 2000;18(1):67-75
references.pmid: 11206841
references.citation: J Biol Chem. 1993 Aug 15;268(23):17597-601
references.pmid: 7688727
references.citation: Arch Biochem Biophys. 2001 Jun 1;390(1):51-6
references.pmid: 11368514
references.citation: Cancer Res. 2002 Oct 15;62(20):5930-8
references.pmid: 12384559
references.citation: Int J Cancer. 2008 Jan 1;122(1):91-9
references.pmid: 17893878
references.citation: J Biol Chem. 2001 Nov 23;276(47):43503-8
references.pmid: 11571304
references.citation: Cancer. 2008 Apr 1;112(7):1632-41
references.pmid: 18260155
references.citation: J Biol Chem. 2001 Jul 6;276(27):24833-42
references.pmid: 11331272
references.citation: Cell. 2005 May 6;121(3):335-48
references.pmid: 15882617
references.citation: Contrib Microbiol. 2006;13:191-199
references.pmid: 16627966
references.citation: Neoplasia. 2007 May;9(5):406-17
references.pmid: 17534446
references.citation: Lab Invest. 2008 Jun;88(6):602-14
references.pmid: 18362906
references.citation: Biochem Soc Symp. 1999;65:111-23
references.pmid: 10320936
references.citation: Cancer Lett. 2006 Jul 8;238(1):30-41
references.pmid: 16046252
references.citation: Ann Oncol. 2007 Jan;18(1):70-76
references.pmid: 17032700
references.citation: Am J Pathol. 1999 May;154(5):1525-37
references.pmid: 10329605
references.citation: Cancer Res. 2005 Nov 1;65(21):9891-8
references.pmid: 16267013
references.citation: Cancer Sci. 2007 Nov;98(11):1652-8
references.pmid: 17894551
references.citation: Glia. 2003 Apr 15;42(2):139-48
references.pmid: 12655598
references.citation: Blood. 2006 Mar 1;107(5):1761-7
references.pmid: 16269611
references.citation: Biochem Pharmacol. 2007 Dec 15;74(12):1702-12
references.pmid: 17904532
references.citation: Microcirculation. 2003 Jun;10(3-4):335-50
references.pmid: 12851650
references.citation: Nat Rev Cancer. 2004 Jul;4(7):540-50
references.pmid: 15229479
references.citation: Nature. 2001 Mar 1;410(6824):24-5
references.pmid: 11242022
references.citation: Mol Cell Biol. 2003 Feb;23(4):1316-33
references.pmid: 12556491
references.citation: Oncogene. 1999 Nov 22;18(49):6845-52
references.pmid: 10602460
references.citation: Br J Cancer. 2001 Sep 14;85(6):891-7
references.pmid: 11556842
references.citation: Cancer Res. 2006 Feb 15;66(4):2181-7
references.pmid: 16489019
references.citation: Cancer Sci. 2007 Jul;98(7):1020-6
references.pmid: 17459055
references.citation: Int J Gynecol Cancer. 2009 Aug;19(6):998-1003
references.pmid: 19820359
references.citation: Science. 1996 May 10;272(5263):872-7
references.pmid: 8629022
references.citation: Hum Pathol. 2007 Nov;38(11):1676-87
references.pmid: 17707463
references.citation: N Engl J Med. 1993 Nov 18;329(21):1550-9
references.pmid: 8155119
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14500-5
references.pmid: 9826729
references.citation: Cancer Res. 1999 Apr 1;59(7):1635-41
references.pmid: 10197640
references.citation: CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
references.pmid: 16514137
references.citation: Int J Cancer. 1996 Sep 4;67(5):695-701
references.pmid: 8782661
references.citation: Gynecol Oncol. 2006 Oct;103(1):226-33
references.pmid: 16631235
references.citation: J Biol Chem. 2007 Feb 16;282(7):4924-4931
references.pmid: 17158885
references.citation: Int J Cancer. 2009 Aug 15;125(4):816-25
references.pmid: 19382180
references.citation: Curr Stem Cell Res Ther. 2007 Jan;2(1):89-103
references.pmid: 18220894